These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 26690771)
1. An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia. Gisev N; Nielsen S; Cama E; Larance B; Bruno R; Degenhardt L Eur J Clin Pharmacol; 2016 Apr; 72(4):469-94. PubMed ID: 26690771 [TBL] [Abstract][Full Text] [Related]
2. The extent and correlates of community-based pharmaceutical opioid utilisation in Australia. Degenhardt L; Gisev N; Cama E; Nielsen S; Larance B; Bruno R Pharmacoepidemiol Drug Saf; 2016 May; 25(5):521-38. PubMed ID: 26781123 [TBL] [Abstract][Full Text] [Related]
3. A nationwide study of the extent and factors associated with fentanyl use in Australia. Gisev N; Larance B; Cama E; Nielsen S; Roxburgh A; Bruno R; Degenhardt L Res Social Adm Pharm; 2018 Mar; 14(3):303-308. PubMed ID: 28455195 [TBL] [Abstract][Full Text] [Related]
4. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine. Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA Med J Aust; 2020 Apr; 212(7):321-327. PubMed ID: 32200566 [TBL] [Abstract][Full Text] [Related]
5. A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs. Arora S; Roxburgh A; Bruno R; Nielsen S; Burns L Drug Alcohol Rev; 2013 Nov; 32(6):574-81. PubMed ID: 23751176 [TBL] [Abstract][Full Text] [Related]
6. Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data. Middleton M; Nielsen S Int J Drug Policy; 2019 Dec; 74():170-173. PubMed ID: 31622949 [TBL] [Abstract][Full Text] [Related]
7. Opportunities and challenges: over-the-counter codeine supply from the codeine consumer's perspective. Nielsen S; Cameron J; Pahoki S Int J Pharm Pract; 2013 Jun; 21(3):161-8. PubMed ID: 23419000 [TBL] [Abstract][Full Text] [Related]
8. Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies. Van Hout MC; Norman I Int J Drug Policy; 2016 Jan; 27():17-22. PubMed ID: 26454626 [TBL] [Abstract][Full Text] [Related]
9. Codeine consumption from over-the-counter anti-cough syrup in Taiwan: A useful indicator for opioid abuse. Lo MY; Ong MW; Lin JG; Sun WZ Acta Anaesthesiol Taiwan; 2015 Dec; 53(4):135-8. PubMed ID: 26646544 [TBL] [Abstract][Full Text] [Related]
10. Supply of codeine combination analgesics from Australian pharmacies in the context of voluntary real-time recording and regulatory change: A simulated patient study. Collins JC; Hillman JM; Schneider CR; Moles RJ Int J Drug Policy; 2019 Dec; 74():216-222. PubMed ID: 31677483 [TBL] [Abstract][Full Text] [Related]
11. To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia? Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L Pharmacoepidemiol Drug Saf; 2018 May; 27(5):550-555. PubMed ID: 29047196 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention. Nielsen S; Cameron J; Lee N J Opioid Manag; 2011; 7(5):363-70. PubMed ID: 22165035 [TBL] [Abstract][Full Text] [Related]
13. Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between. Nielsen S; Van Hout MC Curr Top Behav Neurosci; 2017; 34():59-75. PubMed ID: 26768736 [TBL] [Abstract][Full Text] [Related]
14. The association between the availability of over the counter codeine and the prevalence of non-medical use. Hockenhull J; Wood DM; Fonseca F; Guareschi M; Scherbaum N; Iwanicki JL; Dart RC; Dargan PI Eur J Clin Pharmacol; 2022 Jun; 78(6):1011-1018. PubMed ID: 35244726 [TBL] [Abstract][Full Text] [Related]
15. The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis. Boone CG; Antoniou T; Juurlink DN; von den Baumen TR; Kitchen SA; Richards GC; Tadrous M; Gomes T CMAJ Open; 2021; 9(4):E1181-E1186. PubMed ID: 34906994 [TBL] [Abstract][Full Text] [Related]
16. Attitudes in Australia on the upscheduling of over-the-counter codeine to a prescription-only medication. McCoy J; Bruno R; Nielsen S Drug Alcohol Rev; 2018 Feb; 37(2):257-261. PubMed ID: 28597531 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids. Dale O; Borchgrevink PC; Fredheim OM; Mahic M; Romundstad P; Skurtveit S BMC Public Health; 2015 May; 15():461. PubMed ID: 25934132 [TBL] [Abstract][Full Text] [Related]
18. The upscheduling of combination analgesics containing codeine: the impact on the practice of pharmacists. Hamer AM; Spark MJ; Wood PJ; Roberts E Res Social Adm Pharm; 2014; 10(4):669-78. PubMed ID: 24144932 [TBL] [Abstract][Full Text] [Related]
19. The views of Australian adults experiencing pain on the upscheduling of codeine-containing analgesics to 'prescription only'. Mishriky J; Stupans I; Chan V Int J Clin Pharm; 2021 Apr; 43(2):386-393. PubMed ID: 32301065 [TBL] [Abstract][Full Text] [Related]
20. Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden. Frisk P; Sporrong SK; Ljunggren G; Wettermark B; von Euler M Eur J Clin Pharmacol; 2016 Jun; 72(6):747-54. PubMed ID: 26922586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]